Inflammation and Immunopharmacology

Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro

Article metrics



To investigate the expression of scavenger receptor that binds phosphatidylserine and oxidized lipoprotein (SR-PSOX)/CXC chemokine ligand 16 (CXCL16) in the human monocyte-derived cell line THP-1, and the effect of lentiviral vectors for the stable delivery of SR-PSOX/CXCL16 short hairpin RNA on foam cell formation.


A lentiviral expression vector containing enhanced green fluorescence protein (GFP) and SR-PSOX small interfering RNA (siRNA) (Lenti-SR-PSOXsi), or the control siRNA (Lenti-NC) gene was constructed. A human monocyte-derived cell line THP-1 was transfected with a different multiplicity of infection (MOI) of Lenti-SR-PSOXsi or Lenti-NC, and cultured to obtain stably-transfected THP-1KD and THP-1NC cells. After incubation with oxidatively-modified, low-density lipoprotein (Ox-LDL), the expression of SR-PSOX/CXCL16 mRNA was determined by real-time PCR. The expression of the SR-PSOX/CXCL16 protein was detected by flow cytometry analysis. The effect of Lenti-SR-PSOXsi on foam cell formation was assessed by Oil red O-stain analysis.


Ox-LDL increased the expression of SR-PSOX/CXCL16 mRNA in a time- and dose-dependent manner in THP-1 cells. Four days after transfection with Lenti-SR-PSOXsi (MOI: 100), the percentage of GFP expression cells was over 89.3%. The expression of the SR-PSOX/ CXCL16 mRNA and protein in THP- 1KD cells significantly decreased compared with the parent cells, even the THP-1KD cells stimulated with 40 mg/L Ox-LDL. Ox-LDL uptake experiments in THP-1- and THP-1KD-derived macrophages indicated that SR-PSOX/CXCL16 deficiency decreased the development of macrophage-derived foam cell formation.


The above data showed that SR-PSOX siRNA delivered by using lentiviral vectors in THP-1 cells was a powerful tool for studying the effect of SR-PSOX, and decreased the expression of the SR-PSOX gene by inhibiting macrophage-derived foam cell formation.


  1. 1

    Gleissner CA, Leitinger N, Ley K . Effects of native and modified low-density lipoproteins on monocyte recru itment in atherosclerosis. Hypertension 2007; 50: 276–83.

  2. 2

    Evans CE, Mylchreest S, Charlton-Menys V, Durrington P . The role of hydrostatic pressure in foam cell formation upon exposure of macrophages to LDL and oxidized LDL. Atherosclerosis 2008; 197: 596–601.

  3. 3

    Sun B, Boyanovsky BB, Connelly MA, Shridas P, van der Westhuyzen DR, Webb NR . Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res 2007; 48: 2560–70.

  4. 4

    Eguchi A, Murakami A, Ohigashi H . Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells. FEBS Lett 2006; 580: 3321–8.

  5. 5

    Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007; 100: 1634–42.

  6. 6

    Quan Z, Yang H, Yang Y, Yan B, Cao R, Wen G, et al. Construction and functional analysis of a lentiviral expression vector containing a scavenger receptor (SR-PSOX) that binds uniquely phosphatidylserine and oxidized lipoprotein. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 208–16.

  7. 7

    Matloubian M, David A, Engel S, Ryan JE, Cyster JG . A trans-membrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298–304.

  8. 8

    Hundhausen C, Schulte A, Schulz B, Andrzejewski MG, Schwarz N, von Hundelshausen P, et al. Regulated shedding of transmem-brane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007; 178: 8064–72.

  9. 9

    Hofnagel O, Luechtenborg B, Plenz G, Robenek H . Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 2002; 22: 710–1.

  10. 10

    Jiang X, Shimaoka T, Kojo S, Harada M, Watarai H, Wakao H, et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005; 175: 2051–5.

  11. 11

    Chandrasekar B, Bysani S, Mummidi S . CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004; 279: 3188–96.

  12. 12

    Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, et al. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001; 21: 1796–800.

  13. 13

    Wuttge DM, Zhou X, Sheikine Y, Wagsater D, Stemme V, Hedin U, et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24: 750–5.

  14. 14

    Sheikine Y, Sirsjo A . CXCL16/SR-PSOX-A friend or a foe in atherosclerosis? Atherosclerosis 2008; 197: 487–95.

  15. 15

    Yang PY, Rui YC, Jin YX, Li TJ, Qiu Y, Zhang L, et al. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor expression in U937 foam cells. Acta Pharmacol Sin 2003; 24: 610–4.

  16. 16

    Fish RJ, Kruithof EK . Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol Biol 2004; 5: 9.

  17. 17

    Jiang G, Li T, Qiu Y, Rui Y, Chen W, Lou Y . RNA interference for HIF-1alpha inhibits foam cells formation in vitro. Eur J Pharmacol 2007; 562: 183–90.

  18. 18

    Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001; 25: 402–8.

  19. 19

    Tang Y, Ge YZ, Yin JQ . Exploring in vitro roles of siRNA in cardiovascular disease. Acta Pharmacol Sin 2007; 28: 1–9.

  20. 20

    Wang H, Tan SS, Wang XY, Liu DH, Yu CS, Bai ZL, et al. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin 2007; 28: 1968–74.

  21. 21

    Gao LF, Wen LJ, Yu H, Zhang L, Meng Y, Shao YT, et al. Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo. Acta Pharmacol Sin 2006; 27: 347–52.

  22. 22

    Thomas M, Greil J, Heidenreich O . Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials. Acta Pharmacol Sin 2006; 27: 273–81.

  23. 23

    Yin R, Dong YG, Li HL . PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation. Acta Pharmacol Sin 2006; 27: 1146–52.

  24. 24

    Aslanian AM, Charo IF . Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 2006; 114: 583–90.

  25. 25

    Lougheed M, Lum CM, Ling W, Suzuki H, Kodama T, Steinbrecher U . High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem 1997; 272: 12938–44.

Download references

Author information

Correspondence to Yao-cheng Rui or Li-xin Wei.

Additional information

This project was supported by the National Natural Science Foundation of China (No 30500615), the Young Scholars Foundation of Shanghai Public Health Bureau (No 2004-55-94), and the Young Scholars Foundation of SMMU (No 2005-SQ-11).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, L., Liu, H., Li, T. et al. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro. Acta Pharmacol Sin 29, 847–852 (2008) doi:10.1111/j.1745-7254.2008.00823.x

Download citation


  • CXCL16
  • lentiviral vector
  • small interfering RNA
  • atherosclerosis
  • oxidatively-modified
  • low-density lipoprotein

Further reading